Mitozz is the best choice for mitochondrial support See why ➝

    End of Content.

    Shop Mitozz

    Peer-Reviewed Papers

    Explore published research on mitochondrial function, cellular energy, (-)-epicatechin, vascular biology, and related metabolic pathways. Browse by specialization below to quickly find the papers most relevant to your interests.

    Search Papers by Specialization

    Epicatechin Activates Nrf2 and Cell Signaling Pathways in HepG2 Cells

    Study Title: Epicatechin induces NF-κB, activator protein-1 (AP-1) and nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) via phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) and extracellular regulated kinase (ERK) signalling in HepG2 cells

    Citation: Granado-Serrano et al., 2010 · British Journal of Nutrition

    What the Study Found: This laboratory study examined how epicatechin affects stress-response signaling in HepG2 cells, a human liver-derived cell line. The researchers found that epicatechin activated several transcription factors involved in cellular stress and antioxidant-response biology, including NF-κB, AP-1, and Nrf2.

    The authors reported that these effects involved PI3K/AKT and ERK signaling pathways. Overall, the study suggests that epicatechin may influence how liver-derived cells respond to oxidative and cellular stress, but these findings were observed in a controlled cell-culture model, not in humans.

    What this means in real life: This paper helps explain a possible mechanism behind epicatechin’s biological activity. Rather than acting only as a direct antioxidant, epicatechin may also interact with internal cell-signaling systems that regulate stress response and antioxidant defenses.

    Because this was a cell study, it does not prove that epicatechin improves liver function, reduces inflammation, or treats oxidative stress in people. It is best understood as early mechanistic evidence that may help guide future research.

    Clinical Relevance: Cell/laboratory study using HepG2 cells; epicatechin, NF-κB, AP-1, Nrf2, PI3K/AKT, ERK signaling, oxidative stress biology, and liver-cell signaling pathways; not an animal study, not a human clinical trial, and not evidence of disease treatment or clinical benefit.

    Related Content:

    View Paper

    Human Pharmacokinetic Study of Purified (−)-Epicatechin

    Study Title: Pharmacokinetic, partial pharmacodynamic and initial safety analysis of (−)-epicatechin in healthy volunteers

    Citation: Barnett et al., 2015 · Food & Function

    What the Study Found: This phase I, open-label human study evaluated purified (−)-epicatechin in healthy volunteers. Participants received single oral doses of 50, 100, or 200 mg, or repeated 50 mg doses once or twice daily for 5 days. The researchers measured absorption, metabolism, early safety, and selected biological markers related to nitric oxide signaling, mitochondrial enzyme activity, and muscle-related pathways.

    The authors reported that purified (−)-epicatechin was rapidly absorbed and metabolized, with several metabolites detected in blood. After repeated dosing, the study observed changes in selected biomarkers, including plasma nitrite, platelet mitochondrial enzyme activity, and follistatin measures. No adverse effects attributed to (−)-epicatechin were reported in this small short-term study.

    What this means in real life: This study helps distinguish purified (−)-epicatechin from cocoa, dark chocolate, or mixed flavanol products. It shows that purified (−)-epicatechin can be absorbed and measured in humans, and that it may influence biological pathways connected to nitric oxide signaling, vascular biology, mitochondrial enzyme activity, and muscle-related signaling.

    These findings are preliminary. The study did not test whether (−)-epicatechin improves fatigue, exercise performance, recovery, cardiovascular outcomes, or any disease condition. Larger and longer clinical trials would be needed to evaluate those questions.

    Clinical Relevance: Human phase I pharmacokinetic and partial pharmacodynamic study in healthy volunteers; purified (−)-epicatechin, nitric oxide metabolites, platelet mitochondrial enzyme activity, and follistatin signaling; not a randomized efficacy trial and not evidence that (−)-epicatechin treats, prevents, or cures disease.

    Related Content:

    View Paper

    Chronic Stress, Leydig Cell Mitochondria, and Testosterone Synthesis

    Study Title: Chronic stress inhibits testosterone synthesis in Leydig cells through mitochondrial damage via Atp5a1

    Citation: Xiong et al., 2022 · Journal of Cellular and Molecular Medicine

    What the Study Found: This study examined how chronic stress affects testosterone synthesis in adult male rats and Leydig cells. After 21 days of chronic stress, rats showed lower body weight, reduced genital organ indices, and decreased serum testosterone. Proteomic analysis of testis tissue identified several differentially expressed proteins, with Atp5a1 emerging as a central mitochondrial protein. Atp5a1 expression was reduced in Leydig cells after chronic stress. In TM3 Leydig cells, Atp5a1 knockdown damaged mitochondrial structure and reduced expression of testosterone-synthesis proteins, including StAR, CYP11A1, and 17β-HSD.

    What this means in real life: This paper supports the idea that chronic stress can influence reproductive hormone biology through cellular energy systems, not only through brain-hormone signaling. Leydig cells rely on mitochondria to support steroid production, and this study suggests that mitochondrial damage and reduced Atp5a1 may be part of how chronic stress disrupts testosterone synthesis in this model. This does not mean mitochondrial support treats low testosterone or male infertility. The practical takeaway is that stress biology, mitochondrial integrity, and hormone production are closely connected.

    Clinical Relevance: Rat and Leydig cell study, focused on chronic stress, mitochondrial damage, Atp5a1 expression, and testosterone-synthesis pathways.

    Related Content:

    View Paper

    Mitochondrial Transfer and Testosterone Synthesis

    Study Title: An extracellular vesicle-mediated mitochondrial transfer network critical for testosterone synthesis

    Citation: Xia et al., 2026 · Nature Cell Biology

    What the Study Found: This study described a mitochondrial transfer network between Sertoli cells and Leydig cells that supports testosterone synthesis. The researchers found that Sertoli cells released extracellular vesicles containing mitochondria, which were taken up by Leydig cells. This transfer helped support mitochondrial function, cholesterol handling, and steroidogenic activity needed for testosterone production. The study also reported that disrupting this mitochondrial transfer impaired testosterone synthesis, while restoring transferred mitochondria helped rescue steroidogenic function in the experimental model.

    What this means in real life: This paper adds an important layer to how reproductive hormone biology may depend on cell-to-cell mitochondrial support. Testosterone synthesis is usually discussed through hormones and enzymes, but this study suggests that mitochondrial transfer between neighboring testicular cells can help supply the energy and organelle support needed for steroid production. This does not mean mitochondrial support treats low testosterone or hormonal disorders. The practical takeaway is that reproductive metabolism depends on coordinated cellular energy systems, not isolated cells working alone.

    Clinical Relevance: Mechanistic reproductive biology study, focused on extracellular vesicle-mediated mitochondrial transfer, Sertoli-Leydig cell communication, mitochondrial function, and testosterone synthesis.

    Related Content:

    View Paper

    Indole-3-Propionic Acid, Mitochondrial Respiration, and CD4+ T Cells

    Study Title: Microbial metabolite indole-3-propionic acid drives mitochondrial respiration in CD4+ T cells to confer protection against intestinal inflammation

    Citation: Li et al., 2025 · Nature Metabolism

    What the Study Found: This study examined how the gut microbial metabolite indole-3-propionic acid affects CD4+ T cell metabolism and intestinal inflammation. The researchers found that indole-3-propionic acid increased mitochondrial respiration in CD4+ T cells and supported anti-inflammatory immune programming. In experimental intestinal inflammation models, this mitochondrial effect was associated with protection against inflammatory damage. The paper connects microbial metabolites, T cell energy metabolism, and immune regulation, suggesting that mitochondrial respiration can help shape how CD4+ T cells respond in the gut environment.

    What this means in real life: This paper supports the idea that gut-derived metabolites can influence immune function by changing how immune cells use energy. In this case, indole-3-propionic acid helped drive mitochondrial respiration in CD4+ T cells, which was linked to a more protective response in intestinal inflammation models. This does not mean IPA supplements treat inflammatory bowel disease or intestinal inflammation in humans. The practical takeaway is that the gut microbiome, mitochondrial metabolism, and immune balance are closely connected.

    Clinical Relevance: Mechanistic gut-immunometabolism study, focused on microbial indole-3-propionic acid, CD4+ T cell mitochondrial respiration, and intestinal inflammation models.

    Related Content:

    View Paper

    Mitochondrial Dysfunction and Fatigue

    Study Title: Association of mitochondrial dysfunction and fatigue: A review of the literature

    Citation: Filler et al., 2014 · BBA Clinical

    What the Study Found: This review examined studies connecting fatigue with markers of mitochondrial dysfunction across multiple clinical contexts. The authors found that fatigue is often discussed alongside changes in mitochondrial energy production, oxidative stress, ATP availability, and cellular bioenergetics.

    Because this was a literature review rather than a single intervention trial, it did not report one unified percentage improvement or decline. Instead, the evidence indicates that mitochondrial dysfunction may contribute to fatigue when cells struggle to match energy supply with physiological demand.

    Clinical Relevance: Review article, human and clinical literature synthesis.

    What this means in real life: This paper helps explain why fatigue can feel different from ordinary tiredness. When cellular energy systems are strained, the body may still function, but daily tasks can feel disproportionately effortful. Research suggests that mitochondrial capacity may influence stamina, recovery, and resilience under stress.

    This does not mean all fatigue is caused by mitochondria. Fatigue can also come from sleep disorders, anemia, thyroid issues, infection, depression, medication effects, under-fueling, and other medical causes. But this review supports the idea that cellular energy production is an important layer in the fatigue conversation.

    Related Content:

    View Paper

    Skeletal Muscle Mitochondrial Structure in Type 2 Diabetes and Heart Failure

    Study Title: Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa

    Citation: Taub et al., 2012 · Clinical and Translational Science

    What the Study Found: Patients with type 2 diabetes and heart failure showed clear impairments in skeletal muscle mitochondrial structure and biogenesis markers compared with healthy controls. Supplementation with epicatechin-rich cocoa restored several of these mitochondrial indicators. The changes were accompanied by improvements in energy-production capacity within muscle cells.

    What this means in real life: In type 2 diabetes and heart failure, mitochondria in skeletal muscle become structurally damaged and less able to produce energy, contributing to fatigue and weakness. This study shows that (−)-epicatechin from cocoa can help repair mitochondrial structure and biogenesis markers, directly supporting cellular energy production. At Mitozz we focus on mitochondrial health because restoring this cellular capacity is key to regaining strength and endurance when the heart and metabolism are stressed.

    Related Content

    View Paper

    Mitochondrial Biogenesis in Muscle Cells via GPER

    Study Title: (-)-Epicatechin stimulates mitochondrial biogenesis and cell growth in C2C12 myotubes via the G-protein coupled estrogen receptor

    Citation: Moreno-Ulloa et al., 2018 · European Journal of Pharmacology

    What the Study Found: In cultured C2C12 myotubes, (−)-epicatechin (3 and 10 µM) increased mitochondrial inner and outer membrane markers, NRF-2, TFAM, and citrate synthase activity. It also promoted myotube growth (longer and wider cells). These effects were largely mediated by the G-protein coupled estrogen receptor (GPER), as shown by receptor blockade and siRNA knockdown.

    What this means in real life: Mitochondrial biogenesis in muscle cells is essential for energy production and tissue growth, but it can slow down with age or stress. This study demonstrates that (−)-epicatechin directly stimulates biogenesis and cell growth through the GPER pathway, mimicking some of estrogen’s protective effects on mitochondria. Supporting mitochondrial health helps keep muscle cells energetically robust and responsive to training or daily demands.

    Related Content

    View Paper

    Triglyceride/HDL Ratio and Cardiometabolic Profile

    Study Title: A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects

    Citation: Gutiérrez-Salmeán et al., 2016 · International Journal of Cardiology

    What the Study Found: In hypertriglyceridemic subjects, 100 mg/day of (−)-epicatechin for 4 weeks significantly improved the triglyceride/HDLc ratio and other cardiometabolic markers. In parallel in vitro experiments, (−)-epicatechin reduced fructose-induced triglyceride accumulation and improved mitochondrial function in liver cells. The effects were superior to those of its stereoisomer (+)-catechin.

    What this means in real life: Mitochondria in the liver and muscle are central to balancing fat and sugar metabolism; when they’re stressed, triglycerides rise and HDL falls. This human trial shows that (−)-epicatechin can shift cardiometabolic markers in a favorable direction while directly protecting mitochondrial function in liver cells. Mitochondrial support like this offers a practical way to improve everyday metabolic health and energy efficiency.

    Related Content

    View Paper

    Apelin Receptor Signaling and Biased Agonism

    Study Title: (-)-Epicatechin Is a Biased Ligand of Apelin Receptor

    Citation: Portilla-Martínez et al., 2022 · International Journal of Molecular Sciences

    What the Study Found: Using molecular dynamics simulations and in vitro assays, researchers showed that (−)-epicatechin acts as a biased ligand of the apelin receptor (APLN). It preferentially recruits β-arrestin in its active conformation while modulating downstream signaling pathways. This biased agonism was distinct from unbiased apelin signaling.

    What this means in real life: The apelin receptor helps regulate energy metabolism, vascular tone, and mitochondrial function in heart and muscle cells. This study reveals that (−)-epicatechin can selectively activate beneficial branches of this pathway, supporting cellular energy balance without overstimulating other signals. At Mitozz we focus on mitochondrial health because compounds like (−)-epicatechin that fine-tune energy-related receptors help cells maintain efficient energy production and resilience.

    Related Content •

    View Paper

    eNOS Activation and Nitric Oxide Signaling Pathways

    Study Title: (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways

    Citation: Ramirez-Sanchez et al., 2010 · Hypertension

    What the Study Found: (−)-Epicatechin activated endothelial nitric oxide synthase (eNOS) in human coronary artery cells through specific phosphorylation (Ser633 and Ser1177) and dephosphorylation (Thr495) events. It worked via the PI3K pathway, Ca²⁺/CaMKII signaling, and cell-surface mechanisms. The result was increased nitric oxide production and improved vascular signaling.

    What this means in real life: Mitochondria in endothelial cells supply the energy for nitric oxide production, which keeps arteries flexible and blood pressure healthy. This study shows that (−)-epicatechin rapidly activates eNOS through well-defined signaling routes, enhancing nitric oxide output. Supporting mitochondrial health ensures these energy-dependent pathways stay responsive, helping your vascular system function at its best.

    Related Content

    View Paper

    GPER Receptor and Endothelial Nitric Oxide Production

    Study Title: The effects of (−)-epicatechin on endothelial cells involve the G protein-coupled estrogen receptor (GPER)

    Citation: Moreno-Ulloa et al., 2015 · Pharmacol Res

    What the Study Found: (−)-Epicatechin binds to the G protein-coupled estrogen receptor (GPER) on endothelial cells and activates downstream signaling (ERK 1/2 and CaMKII) via the GPER/c-SRC/EGFR axis. This pathway stimulates nitric oxide production and causes vasodilation in aortic rings. The effects mimic those of a known GPER agonist.

    What this means in real life: Endothelial mitochondria need fast, accurate signals to produce nitric oxide and keep blood vessels relaxed. This study reveals that (−)-epicatechin works through a specific surface receptor (GPER) to trigger those signals, boosting nitric oxide without entering the cell. Mitochondrial support helps keep this energy-dependent vascular communication running smoothly for better circulation and heart health.

    Related Content

    View Paper

    Continue Exploring Mitochondrial Science

    Mitochondria 101  |  Visit Our Blog  |  Join the Community